Table 3.
Top predicted indications for Ustekinumab
| Ranking | Disease | Disease_ID | Prediction_score |
|---|---|---|---|
| 1 | Immune system disease | EFO_0000540 | 0.95580226 |
| 2 | Asthma | EFO_0000270 | 0.94961476 |
| 3 | Rheumatoid arthritis | EFO_0000685 | 0.9285401 |
| 4 | Uveitis | EFO_1001231 | 0.8917595 |
| 5 | Alopecia areata | EFO_0004192 | 0.8835659 |
| 6 | Alzheimer's disease | EFO_0000249 | 0.8625836 |
| 7 | Schizophrenia | EFO_0000692 | 0.862216 |
| 8 | Atopic eczema | EFO_0000274 | 0.84960294 |
| 9 | Takayasu arteritis | EFO_1001857 | 0.8476705 |
| 10 | Temporal arteritis | EFO_1001209 | 0.8364161 |
| 11 | Obesity | EFO_0001073 | 0.8306895 |
| 12 | Multiple sclerosis | EFO_0003885 | 0.82465583 |
| 13 | Osteoarthritis | EFO_0002506 | 0.8140218 |
| 14 | Ulcerative colitis | EFO_0000729 | 0.8110609 |
| 15 | Relapsing–remitting multiple sclerosis | EFO_0003929 | 0.7750288 |
| 16 | Behcet's syndrome | EFO_0003780 | 0.75113726 |
| 17 | Diabetes mellitus | EFO_0000400 | 0.74368954 |
| 18 | Juvenile idiopathic arthritis | EFO_0002609 | 0.7401242 |
| 19 | Non-alcoholic steatohepatitis | EFO_1001249 | 0.7374891 |
| 20 | Systemic lupus erythematosus | EFO_0002690 | 0.73320544 |
| 21 | Ankylosing spondylitis | EFO_0003898 | 0.7330974 |
| 22 | Graft versus host disease | MONDO_0013730 | 0.72582567 |
| 23 | Psoriatic arthritis | EFO_0003778 | 0.71739846 |
| 24 | Alcohol dependence | EFO_0003829 | 0.71080697 |
| 25 | Dermatitis | MONDO_0002406 | 0.7098975 |
| 26 | Crohn's disease | EFO_0000384 | 0.6959177 |
| 27 | HIV-1 infection | EFO_0000180 | 0.6868525 |
| 28 | Periodontitis | EFO_0000649 | 0.6834563 |
| 29 | Tuberculosis | Orphanet_3389 | 0.67681295 |
| 30 | Post-traumatic stress disorder | EFO_0001358 | 0.6721301 |
| 31 | Psoriasis | EFO_0000676 | 0.67159593 |
| 32 | Viral disease | EFO_0000763 | 0.67042077 |
| 33 | Cystic fibrosis | Orphanet_586 | 0.6682126 |
| 34 | Abdominal Aortic Aneurysm | EFO_0004214 | 0.653386 |
| 35 | Psoriasis vulgaris | EFO_1001494 | 0.63942015 |